Skip to main content
PMC home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1992;103:176–181.

Marijuana use and the risk of new onset seizures.

J C Brust 1, S K Ng 1, A W Hauser 1, M Susser 1
PMCID: PMC2376682  PMID: 1413377

Full text

PDF
176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chiu P., Olsen D. M., Borys H. K., Karler R., Turkanis S. A. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats. Epilepsia. 1979 Aug;20(4):365–375. doi: 10.1111/j.1528-1157.1979.tb04816.x. [DOI] [PubMed] [Google Scholar]
  2. Clinical competence and research. Lancet. 1980 Mar 22;1(8169):637–637. [PubMed] [Google Scholar]
  3. Colasanti B. K., Lindamood C., 3rd, Craig C. R. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982 Apr;16(4):573–578. doi: 10.1016/0091-3057(82)90418-x. [DOI] [PubMed] [Google Scholar]
  4. Consroe P. F., Wood G. C., Buchsbaum H. Anticonvulsant nature of marihuana smoking. JAMA. 1975 Oct 20;234(3):306–307. [PubMed] [Google Scholar]
  5. Consroe P., Benedito M. A., Leite J. R., Carlini E. A., Mechoulam R. Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice. Eur J Pharmacol. 1982 Sep 24;83(3-4):293–298. doi: 10.1016/0014-2999(82)90264-3. [DOI] [PubMed] [Google Scholar]
  6. Consroe P., Martin A. R., Fish B. S. Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids. J Med Chem. 1982 May;25(5):596–599. doi: 10.1021/jm00347a021. [DOI] [PubMed] [Google Scholar]
  7. Consroe P., Martin A., Singh V. Antiepileptic potential of cannabidiol analogs. J Clin Pharmacol. 1981 Aug-Sep;21(8-9):428S–436S. doi: 10.1002/j.1552-4604.1981.tb02623.x. [DOI] [PubMed] [Google Scholar]
  8. Consroe P., Martin P., Eisenstein D. Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits. Res Commun Chem Pathol Pharmacol. 1977 Jan;16(1):1–13. [PubMed] [Google Scholar]
  9. Consroe P., Wolkin A. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther. 1977 Apr;201(1):26–32. [PubMed] [Google Scholar]
  10. Cunha J. M., Carlini E. A., Pereira A. E., Ramos O. L., Pimentel C., Gagliardi R., Sanvito W. L., Lander N., Mechoulam R. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980;21(3):175–185. doi: 10.1159/000137430. [DOI] [PubMed] [Google Scholar]
  11. Ehlers C. L., Henriksen S. J., Bloom F. E. Levonantradol potentiates the anticonvulsant effects of diazepam and valproic acid in the kindling model of epilepsy. J Clin Pharmacol. 1981 Aug-Sep;21(8-9):406S–412S. doi: 10.1002/j.1552-4604.1981.tb02620.x. [DOI] [PubMed] [Google Scholar]
  12. Feeney D. M. Letter: Marihuana use among epileptics. JAMA. 1976 Mar 15;235(11):1105–1105. [PubMed] [Google Scholar]
  13. Feeney D. M. Marihuana and epilepsy: paradoxical anticonvulsant and convulsant effects. Adv Biosci. 1978 Jul 22;22-23:643–657. doi: 10.1016/b978-0-08-023759-6.50053-6. [DOI] [PubMed] [Google Scholar]
  14. Fish B. S., Consroe P., Fox R. R. Inheritance of delta 9-tetrahydrocannabinol seizure susceptibility in rabbits. J Hered. 1981 May-Jun;72(3):215–216. doi: 10.1093/oxfordjournals.jhered.a109475. [DOI] [PubMed] [Google Scholar]
  15. Fish B. S., Consroe P. The ontogeny of delta-9-tetrahydrocannabinol responsiveness in the rabbit. Dev Psychobiol. 1983 Mar;16(2):147–158. doi: 10.1002/dev.420160207. [DOI] [PubMed] [Google Scholar]
  16. Ghosh P., Bhattacharya S. K. Anticonvulsant action of cannabis in the rat: role of brain monoamines. Psychopharmacology (Berl) 1978 Dec 8;59(3):293–297. doi: 10.1007/BF00426637. [DOI] [PubMed] [Google Scholar]
  17. Izquierdo I., Tannhauser M. Letter: The effect of cannabidiol on maximal electroshock seizures in rats. J Pharm Pharmacol. 1973 Nov;25(11):916–917. doi: 10.1111/j.2042-7158.1973.tb09976.x. [DOI] [PubMed] [Google Scholar]
  18. Johnson D. D., McNeill J. R., Crawford R. D., Wilcox W. C. Epileptiform seizures in domestic fowl. V. The anticonvulsant activity of delta9-tetrahydrocannabinol. Can J Physiol Pharmacol. 1975 Dec;53(6):1007–1013. doi: 10.1139/y75-140. [DOI] [PubMed] [Google Scholar]
  19. Karler R., Cely W., Turkanis S. A. Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids. Life Sci. 1974 Sep 1;15(5):931–947. doi: 10.1016/0024-3205(74)90009-5. [DOI] [PubMed] [Google Scholar]
  20. Karler R., Turkanis S. A. Cannabis and epilepsy. Adv Biosci. 1978 Jul 22;22-23:619–641. doi: 10.1016/b978-0-08-023759-6.50052-4. [DOI] [PubMed] [Google Scholar]
  21. Karler R., Turkanis S. A. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice. Br J Pharmacol. 1980 Mar;68(3):479–484. doi: 10.1111/j.1476-5381.1980.tb14562.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Karler R., Turkanis S. A. The cannabinoids as potential antiepileptics. J Clin Pharmacol. 1981 Aug-Sep;21(8-9):437S–448S. doi: 10.1002/j.1552-4604.1981.tb02624.x. [DOI] [PubMed] [Google Scholar]
  23. Mechoulam R., Carlini E. A. Toward drugs derived from cannabis. Naturwissenschaften. 1978 Apr;65(4):174–179. doi: 10.1007/BF00450585. [DOI] [PubMed] [Google Scholar]
  24. Meldrum B. S., Fariello R. G., Puil E. A., Derouaux M., Naquet R. Delta9-tetrahydrocannabinol and epilepsy in the photosensitive baboon, Papio papio. Epilepsia. 1974 Jun;15(2):255–264. doi: 10.1111/j.1528-1157.1974.tb04947.x. [DOI] [PubMed] [Google Scholar]
  25. Perez-Reyes M., Wingfield M. Letter: Cannabidiol and electroencephalographic epileptic activity. JAMA. 1974 Dec 23;230(12):1635–1635. [PubMed] [Google Scholar]
  26. Razdan R. K., Terris B. Z., Pars H. G., Plotnikoff N. P., Dodge P. W., Dren A. T., Kyncl J., Somani P. Drugs derived from cannabinoids. 2. Basic esters of nitrogen and carbocyclic analogs. J Med Chem. 1976 Apr;19(4):454–461. doi: 10.1021/jm00226a002. [DOI] [PubMed] [Google Scholar]
  27. Sofia R. D., Solomon T. A., Barry H., 3rd Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs. Eur J Pharmacol. 1976 Jan;35(1):7–16. doi: 10.1016/0014-2999(76)90295-8. [DOI] [PubMed] [Google Scholar]
  28. Ten Ham M., Loskota W. J., Lomax P. Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil. Eur J Pharmacol. 1975 Mar;31(1):148–152. doi: 10.1016/0014-2999(75)90087-4. [DOI] [PubMed] [Google Scholar]
  29. Turkanis S. A., Karler R. Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats. Neuropharmacology. 1982 Jan;21(1):7–13. doi: 10.1016/0028-3908(82)90204-0. [DOI] [PubMed] [Google Scholar]
  30. Turkanis S. A., Karler R. Electrophysiologic properties of the cannabinoids. J Clin Pharmacol. 1981 Aug-Sep;21(8-9):449S–463S. doi: 10.1002/j.1552-4604.1981.tb02625.x. [DOI] [PubMed] [Google Scholar]
  31. Turkanis S. A., Smiley K. A., Borys H. K., Olsen D. M., Karler R. An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats. Epilepsia. 1979 Aug;20(4):351–363. doi: 10.1111/j.1528-1157.1979.tb04815.x. [DOI] [PubMed] [Google Scholar]
  32. Wada J. A., Osawa T., Corcoran M. E. Effects of tetrahydrocannabinols on kindled amygdaloid seizures and photogenic seizures in Senegalese baboons, Papio papio. Epilepsia. 1975 Sep;16(3):439–448. doi: 10.1111/j.1528-1157.1975.tb06071.x. [DOI] [PubMed] [Google Scholar]
  33. Wada J. A., Wake A., Sato M., Corcoran M. E. Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats. Epilepsia. 1975 Sep;16(3):503–510. doi: 10.1111/j.1528-1157.1975.tb06080.x. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES